Amresh Kumar

Amresh Kumar is a declared insider of Acasti Pharma Inc., with filings sourced from SEDI. We count 3 filings; the first trade dates from 8 May 2023 and the latest from 10 July 2023.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The newest entry dates from 14 July 2023: a transaction, in Acasti Pharma Inc. The median gap between a trade and its publication by SEDI is 4 days. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.